Open AccessTOWARDS INDIVIDUALIZED TREATMENT OF KIDNEY TRANSPLANT RECIPIENTS: PRETRANSPLANT ANTI DONOR CELLULAR IMMUNITY BY IFN-?? ELISPOT IDENTIFIES CANDIDATES THAT CAN MOST BENEFIT FROM INDUCTION THERAPY.
Author(s) -
AUTHOR_ID
Publication year - 2006
Publication title -
transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.45
H-Index - 204
eISSN - 1534-6080
pISSN - 0041-1337
DOI - 10.1097/00007890-200607152-01747
Subject(s) - elispot , medicine , kidney transplant , immunology , kidney transplantation , induction therapy , kidney , immunity , immunotherapy , immune system , t cell , chemotherapy